Aducanumab: Biogen to seek US FDA approval
Biogen (MA, USA) and Eisai Co. (Tokyo, Japan) have announced plans to pursue regulatory approval…
Browsing: dementia
SfN19: How might the gut–brain connection impact brain health in mice?
Four studies presented at SfN Neuroscience have demonstrated how the microbiome interacts with the brain in mice, revealing the possible mechanisms behind gut–brain communication.
SfN19: Metabolic disturbances in the brain may exacerbate and forewarn Alzheimer’s pathology in mice
Abstracts presented at SfN Neuroscience 2019 have revealed that metabolic disturbances in the brain could exacerbate and forewarn Alzheimer’s pathology in mice.
Signs of dementia may be detected earlier in women with new diagnostic criteria
Researchers have discovered that more women and less men are diagnosed with amnestic mild cognitive impairment when sex-specific scores are used.
The importance of prevention trials in Alzheimer’s disease with Randall Bateman
What are the main challenges surrounding primary prevention trials for Alzheimer’s? Should researchers be exploring alternative avenues to amyloid-β in these trials? Take a look at our interview with Randall Bateman to find out more.
Ask the Experts: The future of dementia research
In this written ‘Ask the Experts’ column, we bring together leaders from our partnered organizations (Alzheimer’s Research UK, Alzheimer’s Society and the UK DRI) to discuss what the future of dementia research might hold.
Blood pressure changes in mid-30s linked to poorer brain health
The Insight 46 study has indicated that changes in blood pressure in people as young as 36 may be linked to poorer brain health later in life.
A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery
Genetic therapies represent a remarkable avenue for potentially slowing and preventing neurodegenerative diseases. This includes a first-in-human, gene-silencing treatment for Alzheimer’s disease. Find out more on this from Catherine Mummery.
Translating blood biomarkers into the clinic for neurodegenerative diseases with Henrik Zetterberg
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
A blood test for early Alzheimer’s disease demonstrates 94% accuracy in diagnosis
A blood test to diagnose individuals at risk of developing Alzheimer’s disease before symptoms arise may be closer to reality, as researchers report a 94% accuracy in recent findings.
